# OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness

> **NCT05677763** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **OM Pharma SA** · enrollment: 525 (actual)

## Conditions studied

- Respiratory Tract Infections
- Wheezing Lower Respiratory Illness

## Interventions

- **DRUG:** OM-85
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05677763
- **Lead sponsor:** OM Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-12-12
- **Primary completion:** 2026-03-10
- **Final completion:** 2026-09-16
- **Target enrollment:** 525 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05677763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05677763, "OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05677763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*